| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 08/31/2006 | US20060193832 Use of the sodium iodine symporter to effect uptake of iodine |
| 08/31/2006 | US20060193775 Embedder compositions and methods for detecting and killing cells in acidic areas of tumors |
| 08/31/2006 | US20060193774 Transporter compositions and methods for detecting and killing cells in acidic areas of tumors |
| 08/31/2006 | US20060193773 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma |
| 08/31/2006 | US20060193772 Drugs for treating cancer |
| 08/31/2006 | US20060193771 Anti-cd30 stalk and anti-cd30 antibodies suitable for use in immunotoxins |
| 08/31/2006 | US20060193770 Bioassay of measuring tyrosine-kinase ligand, tumor necrosis factor and transforming growth factor level, before administering the myelosuppressive agent to the patient; use in optimizing treatment and avoiding toxic effects |
| 08/31/2006 | US20060193769 Drug releasing biodegradable fiber for delivery of therapeutics |
| 08/31/2006 | US20060193768 Technetium-base radiopharmaceuticals; biocompatability; kits; in vivo imaging of a human or animal body |
| 08/31/2006 | CA2598863A1 Radiolabeled gallium complexes, methods for synthesis and use for pet imaging of egfr epxression in malignant tumors |
| 08/31/2006 | CA2598279A1 Dosage and method for attaining beneficial levels of vitamin d3 |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1695986A2 Anti-erb B2 antibodies |
| 08/30/2006 | EP1695977A2 Spiro [isobenzofuran-1,4'piperidin]-3-ones and 3H-spiroisobenzofuran-1, 4'-piperidines |
| 08/30/2006 | EP1694636A1 Methods for carbon isotope labeling synthesis by rhodium-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide |
| 08/30/2006 | EP1583563B1 Method for the production of hyperpolarized 129xe |
| 08/30/2006 | EP1283729B1 Tc and re carbonyl complexes prepared from pertechnetates and perrhenates |
| 08/30/2006 | CN1826139A Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 08/30/2006 | CN1826138A Rg1 antibodies and uses thereof |
| 08/30/2006 | CN1824333A Preparation method of interpose internal radiation anti tumour series medicine |
| 08/29/2006 | US7098187 for inhibiting endothelial cell proliferation or endothelial tube formation in in vitro or in vivo bioassay |
| 08/29/2006 | US7097839 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs |
| 08/29/2006 | US7097826 Conjugates of ditetratriethylamine pentacarboxylic acid (DTPA) and bisaminoethanethiol (N2S2); for magnetic resonance (MR) imaging; for tumor visualization and necrosis |
| 08/29/2006 | US7097824 Diagnosis images |
| 08/29/2006 | US7097823 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); osteomyelitis treatment |
| 08/24/2006 | WO2006088476A2 Carboranylporphyrins and uses thereof |
| 08/24/2006 | WO2006088473A2 Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents |
| 08/24/2006 | WO2006086870A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 08/24/2006 | WO2005105158A3 Clean room guided conveyor |
| 08/24/2006 | US20060189567 Compound having affinity with calcified tissue |
| 08/24/2006 | US20060188560 Delivery system for nucleic acids |
| 08/24/2006 | US20060188442 X-ray guided drug delivery |
| 08/24/2006 | US20060188441 Radiolabeled gallium complexes, methods for synthesis and use for PET imaging of EGFR expression in malignant tumors |
| 08/24/2006 | US20060188440 Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer |
| 08/24/2006 | US20060188439 Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection |
| 08/24/2006 | US20060188438 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 08/24/2006 | US20060188437 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 08/24/2006 | CA2598522A1 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 08/24/2006 | CA2597958A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 08/24/2006 | CA2567468A1 Carboranylporphyrins and uses thereof |
| 08/23/2006 | EP1691847A2 Tame based chelators and uses thereof |
| 08/23/2006 | EP1691846A1 Peptides whose uptake by cells is controllable |
| 08/23/2006 | EP1691845A1 Compounds containing matrix metalloproteinase substrates and methods of their use |
| 08/23/2006 | EP1691840A2 Psma formulations and uses thereof |
| 08/23/2006 | EP1691838A2 Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs |
| 08/23/2006 | EP1691664A2 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
| 08/23/2006 | EP1691661A2 Soluble tcr molecules and methods of use |
| 08/23/2006 | EP1399401B1 Solid-phase electrophilic fluorination |
| 08/23/2006 | EP1363920B1 Modified psma ligands and uses related thereto |
| 08/23/2006 | EP1358318B1 Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| 08/23/2006 | EP1292612B1 Glycopeptide phosphonate derivatives |
| 08/23/2006 | EP1173226B1 Fatty acid analogs for diagnosis of coronary artery disease |
| 08/23/2006 | CN1822861A Stable radiopharmaceutical compositions and methods for preparation |
| 08/23/2006 | CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/22/2006 | US7094885 Anticancer agents; antiproliferative agents; autoimmune diseases; infection therapy; metabolism diseases |
| 08/22/2006 | US7094580 Methods for producing pure perlecan and other heparan sulfate proteoglycans |
| 08/22/2006 | US7094535 Nucleic acid ligands to integrins |
| 08/22/2006 | CA2331812C 13c glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control |
| 08/17/2006 | WO2006084382A1 Compositions and methods for multimodal imaging |
| 08/17/2006 | WO2005089813A3 Receptor-avid exogenous optical contrast and therapeutic agents |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060182718 Methods and compositions comprising DNA damaging agents and p53 |
| 08/17/2006 | US20060182684 non-invasive and flexible method and carrier for drug delivery across the blood-brain barrier; brain tumors, brain metastases, stroke, schizophrenia, epilepsy, Alzheimer's, Parkinson's and Huntington's disease |
| 08/17/2006 | US20060182683 Methods for reduced renal uptake of protein conjugates |
| 08/17/2006 | US20060182682 Diagnosis of prostate cancer |
| 08/17/2006 | CA2596595A1 Compositions and methods for multimodal imaging |
| 08/17/2006 | CA2595526A1 Colonic delivery of active agents |
| 08/16/2006 | EP1690552A2 Radiopharmaceutical kits stabilised by means of cyclodextrins |
| 08/16/2006 | EP1689675A2 Method and apparatus for synthesis of 11c| phosgen using concentrated 11c| carbon monoxide with uv light |
| 08/16/2006 | EP1689448A2 Improved method for preparing conjugates of proteins and chelating agents |
| 08/16/2006 | EP1689425A1 Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications |
| 08/16/2006 | EP1689228A2 Methods, compositions and devices for inducing stasis in cells |
| 08/16/2006 | EP1272225B1 Lipid-based systems for targeting diagnostic agents |
| 08/15/2006 | US7090844 monoclonal antibody comprising a heavy chain amino acid; treatment of disorders associated with increased activity of MUC18, in particular, tumors, such as melanomas. |
| 08/15/2006 | US7090828 Vitronectin receptor antagonist pharmaceuticals |
| 08/10/2006 | WO2006083983A2 Bridgehead radiolabelled compounds and methods of using the same |
| 08/10/2006 | WO2006083424A2 Radiolabeled compounds and uses thereof |
| 08/10/2006 | WO2006083378A2 IN VIVO MONITORING OF β-AMYLOID PLAQUES AND NEUROFIBRILLARY TANGLES |
| 08/10/2006 | WO2006082434A1 Caspase-3 substrate comprising imaging agents |
| 08/10/2006 | WO2006082108A2 Imaging method and composition for imaging vascular diseases |
| 08/10/2006 | US20060178295 androgen steroid conjugated with one or more mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit a synergistic action together with a cytoskeleton-acting drug such as Taxol (reg); prostate cancer |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177374 Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments |
| 08/10/2006 | US20060177373 Low density radionuclide-containing particulate material |
| 08/10/2006 | CA2593323A1 Bridgehead labelled compounds and methods of using the same |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1687034A1 Contrast agent for medical imaging techniques and usage thereof |
| 08/09/2006 | EP1372741B1 Morpholino imaging and therapy |
| 08/09/2006 | EP0827513B1 Reagents for treatment and diagnostic visualisation, particularly in cancer |
| 08/09/2006 | CN1816357A Thermogelling polymer blends for biomaterial applications |
| 08/09/2006 | CN1268629C Isonitrile compound for radioactive Tc-99m label and its preparing and application |
| 08/08/2006 | US7087724 Carrier molecules |
| 08/08/2006 | US7087722 Fibrin binding domain polypeptides and uses and methods of producing same |
| 08/08/2006 | US7087212 Multilayer binding; lamellar surface structure |
| 08/08/2006 | CA2253429C 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists |
| 08/03/2006 | WO2006081418A2 Ephb receptor-binding peptides |
| 08/03/2006 | WO2006080993A1 Novel cationic metal complex radiopharmaceuticals |
| 08/03/2006 | WO2006055855A3 Method of imaging cell death in vivo |
| 08/03/2006 | WO2006032911A3 Metalloproteinase inhibitor imaging agents |